AstraZeneca Appeals Toprol-XL Patent Invalidity
Pharmaceutical company AstraZeneca PLC is appealing a federal court ruling that scuttled its patents for the valuable heart drug Toprol-XL and threatened its pipeline of branded drugs....To view the full article, register now.
Already a subscriber? Click here to view full article